Your browser doesn't support javascript.
loading
Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease.
Maniscalco, V; Marrani, E; Rossi, E; Maccora, I; Mastrolia, M V; Simonini, G.
Affiliation
  • Maniscalco V; Rheumatology Unit, Meyer Children's University Hospital, Pediatric Residency, University of Florence, Florence, Italy.
  • Marrani E; Rheumatology Unit, Meyer Children's University Hospital, Pediatric Residency, University of Florence, Florence, Italy.
  • Rossi E; Department of Imaging, Meyer Children's University Hospital, Florence, Italy.
  • Maccora I; Rheumatology Unit, Meyer Children's University Hospital, Pediatric Residency, University of Florence, Florence, Italy.
  • Mastrolia MV; Rheumatology Unit, Meyer Children's University Hospital, Pediatric Residency, University of Florence, Florence, Italy.
  • Simonini G; Department of Imaging, Meyer Children's University Hospital, Florence, Italy.
Scand J Rheumatol ; 50(6): 491-492, 2021 11.
Article in En | MEDLINE | ID: mdl-33729083
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Scand J Rheumatol Year: 2021 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Scand J Rheumatol Year: 2021 Document type: Article Affiliation country: Italia